March 24, 2008 — Medtronic, Inc. (NYSE: MDT) announced that it has reached the milestone of more than one million sensors for its continuous glucose monitoring (CGM) products manufactured and sold. The recipient of the milestone one millionth sensor was Tim Parker of San Jose, Calif. Parker, diagnosed with type 1 diabetes 11 years ago, has used CGM therapy for two years to help him manage his diabetes. “Today we salute Tim, thousands of patients like him and all of the Medtronic employees who have contributed to the success of our CGM technology,” said Chris O’Connell, president of the Diabetes business at Medtronic. “Medtronic pioneered CGM 10 years ago, and this important milestone demonstrates our momentum and clear industry leadership in the exciting new field of continuous glucose monitoring.”
Parker relies on his Paradigm™ REAL-Time System, and says it is fundamental to managing his diabetes effectively. Prior to adopting integrated insulin pump and CGM therapy, Parker – like many people with diabetes – experienced unexplained blood glucose excursions that worried him. “I would go to bed with my blood glucose levels at 110 and wake up at 220. What could be happening to my body while I was asleep?” said Parker. Motivated to keep his blood glucose in check, he began researching options and learned about Medtronic’s CGM products on the Internet... Medtronic's Press Release -
